Phase I clinical evaluation of 99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer.
Bragina O, Chernov V, Larkina M, Rybina A, Zelchan R, Garbukov E, Oroujeni M, Loftenius A, Orlova A, Sörensen J, Frejd FY, Tolmachev V.
Bragina O, et al. Among authors: rybina a.
Theranostics. 2023 Sep 4;13(14):4858-4871. doi: 10.7150/thno.86770. eCollection 2023.
Theranostics. 2023.
PMID: 37771776
Free PMC article.
Clinical Trial.